Barclays PLC Reduces Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Barclays PLC lessened its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 27.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 382,507 shares of the real estate investment trust’s stock after selling 145,566 shares during the quarter. Barclays PLC owned about 0.14% of Omega Healthcare Investors worth $15,568,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Allworth Financial LP lifted its position in shares of Omega Healthcare Investors by 12.0% during the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock worth $93,000 after purchasing an additional 244 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in Omega Healthcare Investors by 29.4% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock worth $51,000 after buying an additional 286 shares in the last quarter. Cutter & CO Brokerage Inc. boosted its position in Omega Healthcare Investors by 3.7% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock valued at $281,000 after buying an additional 290 shares during the last quarter. NCP Inc. grew its stake in shares of Omega Healthcare Investors by 10.3% during the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock valued at $113,000 after acquiring an additional 310 shares in the last quarter. Finally, V Square Quantitative Management LLC grew its stake in shares of Omega Healthcare Investors by 49.5% during the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after acquiring an additional 323 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Insider Buying and Selling

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Mizuho increased their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a report on Thursday, December 5th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a research note on Thursday, October 31st. Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Finally, Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $40.18.

Omega Healthcare Investors Price Performance

OHI opened at $39.21 on Monday. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The company’s 50-day moving average price is $40.38 and its 200 day moving average price is $37.97. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42. The firm has a market cap of $10.58 billion, a price-to-earnings ratio of 28.83, a price-to-earnings-growth ratio of 1.21 and a beta of 0.98.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.83%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.